Lannett Company Inc (LCI):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Lannett Company Inc (LCI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10032
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:52
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Lannett Company Inc (Lannett) is a pharmaceutical company. It develops, manufactures and distributes generic prescription pharmaceutical products in tablet, capsule and oral liquid forms. The company offers generic pharmaceuticals for medical indications such as antibiotic, cardiovascular, central nervous systems, gallstone, gastrointestinal, glaucoma, gout, migraine, muscle relaxant, obesity, pain management, respiratory, thyroid deficiency and urinary. Lannett also offers laboratory services, product formulation and development services, granulation, blending, encapsulation, compression, coating and packaging solid dosage forms. The company sells its pharmaceutical products across the US to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private-label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations and health maintenance organizations. Lannett is headquartered in Philadelphia, Pennsylvania, the US.

Lannett Company Inc (LCI) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Lannett Company Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Lannett Company Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Lannett Company Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Lannett Company Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Lannett Company Inc, Medical Devices Deals, 2012 to YTD 2018 11
Lannett Company Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
Lannett Company Inc, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Lannett Acquires Portfolio of Generic Products from Endo International 13
Lannett to Acquire Estradiol Tablets and Selegiline Hydrochloride Capsules 14
Partnerships 15
Lannett Enters into Distribution Agreement with Aralez Pharma 15
Lannett to Form Partnership with YiChang HEC ChangJiang Pharmaceutical 16
Lannett Enters into Co-Marketing Agreement with Sunshine Lake 17
Panacea Biotec Enters Into R&D Agreement With Kremers Urban For Generic Drugs 18
Licensing Agreements 19
Lannett Amends Licensing Agreement with Andor Pharma 19
Equity Offering 20
Lannett Company Files Registration Statement to Raise Funds through Public Offering of Securities 20
Lannett Completes Public Offering Of Shares For US$76.5 Million 21
Lannett Files Shelf Registration Statement For Public Offering Of Securities For Up To US$64 Million 22
Acquisition 23
Lannett Company Plans to Sell Cody Laboratories 23
Lannett Acquires Kremers Urban Pharma for USD1.23 Billion 24
Lannett Acquires Silarx Pharma for USD42 Million 26
Lannett Company Inc – Key Competitors 27
Lannett Company Inc – Key Employees 28
Lannett Company Inc – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 30
Financial Announcements 30
Aug 20, 2018: Lannett announces preliminary fiscal 2018 fourth-quarter and full-year financial results 30
May 07, 2018: Lannett Announces Fiscal 2018 Third-Quarter Financial Results 31
Feb 07, 2018: Lannett Announces Fiscal 2018 Second-Quarter Financial Results; Reports Record Revenues, Strong Earnings 32
Nov 06, 2017: Lannett Reports Solid Fiscal 2018 First-Quarter Financial Results, Significantly Increases Fiscal 2018 Guidance 33
Aug 23, 2017: Lannett Reports Fiscal 2017 Fourth-Quarter And Full-Year Financial Results, Provides Guidance For Fiscal 2018 34
Aug 08, 2017: Lannett Announces Preliminary Fiscal 2017 Fourth-Quarter And Full-Year Financial Results, Comments On Fiscal 2018 Outlook 35
May 02, 2017: Lannett Reports Fiscal 2017 Third-Quarter Financial Results 36
Feb 01, 2017: Lannett Reports Fiscal 2017 Second-Quarter Financial Results 37
Corporate Communications 38
Apr 30, 2018: Lannett Announces Changes To Board Of Directors 38
Apr 20, 2018: Lannett Names Maureen Cavanaugh Senior Vice President And Chief Commercial Operations Officer 39
Jan 18, 2018: Lannett Appoints Timothy C. Crew As Board Of Directors 40
Dec 21, 2017: Lannett Appoints Timothy C. Crew As CEO 41
Sep 25, 2017: Lannetts Board Of Directors Initiates CEO Search 42
Jul 17, 2017: Lannett Appoints Samuel H. Israel As General Counsel 43
Jun 20, 2017: Lannett Names Patrick G. LePore To Board of Directors 44
Legal and Regulatory 45
Nov 01, 2017: Lannett Comments On Amended Civil Complaint 45
Product News 46
Jul 23, 2018: Lannett Announces Multiple Product Launches 46
06/26/2017: Lannett Receives Approval For Additional Dosage Strengths Of Hydrocodone Bitartrate And Acetaminophen Tablets USP 47
Other Significant Developments 48
Jun 29, 2018: Lannett Announces Restructuring Plan Of Cody Laboratories Subsidiary 48
Mar 12, 2018: Lannett Adds New Revenue Streams, Announces Agreements With Three Strategic Alliance Partners 49
Mar 30, 2017: Lannett Voluntarily Pays Down Additional $25 Million Of Revolving Credit Facility 50
Feb 07, 2017: Lannett Announces Successful Completion Of ERP System Extraction 51
Appendix 52
Methodology 52
About GlobalData 52
Contact Us 52
Disclaimer 52

List of Tables
Lannett Company Inc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Lannett Company Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Lannett Company Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Lannett Company Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Lannett Company Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Lannett Company Inc, Medical Devices Deals, 2012 to YTD 2018 11
Lannett Company Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
Lannett Acquires Portfolio of Generic Products from Endo International 13
Lannett to Acquire Estradiol Tablets and Selegiline Hydrochloride Capsules 14
Lannett Enters into Distribution Agreement with Aralez Pharma 15
Lannett to Form Partnership with YiChang HEC ChangJiang Pharmaceutical 16
Lannett Enters into Co-Marketing Agreement with Sunshine Lake 17
Panacea Biotec Enters Into R&D Agreement With Kremers Urban For Generic Drugs 18
Lannett Amends Licensing Agreement with Andor Pharma 19
Lannett Company Files Registration Statement to Raise Funds through Public Offering of Securities 20
Lannett Completes Public Offering Of Shares For US$76.5 Million 21
Lannett Files Shelf Registration Statement For Public Offering Of Securities For Up To US$64 Million 22
Lannett Company Plans to Sell Cody Laboratories 23
Lannett Acquires Kremers Urban Pharma for USD1.23 Billion 24
Lannett Acquires Silarx Pharma for USD42 Million 26
Lannett Company Inc, Key Competitors 27
Lannett Company Inc, Key Employees 28
Lannett Company Inc, Other Locations 29
Lannett Company Inc, Subsidiaries 29

List of Figures
Lannett Company Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Lannett Company Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Lannett Company Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Lannett Company Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Lannett Company Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Lannett Company Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Lannett Company Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Lannett Company Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Lannett Company Inc, Medical Devices Deals, 2012 to YTD 2018 11

★海外企業調査レポート[Lannett Company Inc (LCI):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Lepu Medical Technology (Beijing) Co Ltd (300003)-製薬・医療分野:企業M&A・提携分析
    Summary Lepu Medical Technology (Beijing) Co Ltd (Lepu Medical) is a medical device company that designs, develops, and distributes medical equipments. The company’s products include interventional cardiology products, cardiac in vitro diagnosis products, occlusion devices, pacemaker, angiographic e …
  • BioPorto Diagnostics AS:医療機器:M&Aディール及び事業提携情報
    Summary BioPorto Diagnostics AS (BioPorto Diagnostics), formerly AntibodyShop AS is an in-vitro diagnostics company that manufactures and markets antibodies and antibody based products. The company’s products include matched reagent set, immunoassays, antigens, antibodies, controls calibrators and m …
  • Helius Medical Technologies Inc (HSM):製品パイプライン分析
    Summary Helius Medical Technologies Inc (HMT) is a medical device company that offers neurological wellness solutions. The company offers development, licensing and acquisition of non-invasive platform technologies for amplifying the brain’s ability to heal itself. It offers development of technolog …
  • RCR Tomlinson Ltd (RCR):企業の財務・戦略的SWOT分析
    RCR Tomlinson Ltd (RCR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Best Western International Inc:企業の戦略・SWOT・財務情報
    Best Western International Inc - Strategy, SWOT and Corporate Finance Report Summary Best Western International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • ADOBE Inc (ADBE):企業の財務・戦略的SWOT分析
    ADOBE Inc (ADBE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Banco Colpatria Multibanca Colpatria S.A.:企業の戦略・SWOT・財務情報
    Banco Colpatria Multibanca Colpatria S.A. - Strategy, SWOT and Corporate Finance Report Summary Banco Colpatria Multibanca Colpatria S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Kukje Pharmaceutical Industry Co Ltd (002720):企業の財務・戦略的SWOT分析
    Summary Kukje Pharmaceutical Industry Co Ltd (Kukje) is a manufacturer, and distributor of pharmaceuticals, cosmetics and healthcare products. The company’s products include cephalosporins, penicillins, quinolones, aminoglycosides, macrolides, other antibiotics, antifungal and antiviral agents. Kukj …
  • Omnova Solutions Inc (OMN):企業の財務・戦略的SWOT分析
    Omnova Solutions Inc (OMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Eastman Chemical Co (EMN):企業の財務・戦略的SWOT分析
    Eastman Chemical Co (EMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Eagle Pharmaceuticals Inc (EGRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Eagle Pharmaceuticals Inc (Eagle Pharma) is a specialty pharmaceutical company that offers proprietary pharmaceutical injectables in the therapy areas of critical care, oncology, and various orphan diseases. The company’s commercial product portfolio encompasses pharmaceutical injectables, i …
  • Statewide Superannuation Pty Ltd:企業の戦略的SWOT分析
    Statewide Superannuation Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • CanBas Co Ltd (4575)-製薬・医療分野:企業M&A・提携分析
    Summary CanBas Co Ltd (CanBas) is a clinical stage biopharmaceutical company that provides drugs. The company discovers and develops of novel therapeutics in the field of oncology targeting the cell cycle. It product under development is CBP501, a modified synthetic peptide enhancing the efficacy of …
  • Zafgen Inc (ZFGN):製薬・医療:M&Aディール及び事業提携情報
    Summary Zafgen Inc (Zafgen) is a clinical-stage biopharmaceutical company that develops transformative therapies for patients affected by a range of metabolic diseases. Its pipeline product portfolio includes ZGN-1061, a small molecule MetAP2 inhibitor being developed for patients with type 2 diabet …
  • Japan Foods Co Ltd:企業の戦略・SWOT・財務情報
    Japan Foods Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Japan Foods Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Mississippi Power Co:企業の戦略的SWOT分析
    Mississippi Power Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • SolarCity Corporation-エネルギー分野:企業M&A・提携分析
    Summary SolarCity Corporation (SolarCity), a subsidiary of Tesla, Inc., is a vertically integrated solar energy systems provider that designs, permits, finances, and installs the solar energy and storage systems,. The company also performs maintenance and monitoring services. It procures various com …
  • Mendes Junior Trading E Engenharia SA:企業の戦略・SWOT・財務情報
    Mendes Junior Trading E Engenharia SA - Strategy, SWOT and Corporate Finance Report Summary Mendes Junior Trading E Engenharia SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Bio-Reference Laboratories Inc:企業の戦略的SWOT分析
    Bio-Reference Laboratories Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Taisho Pharmaceutical Holdings Co Ltd:企業のM&A・事業提携・投資動向
    Taisho Pharmaceutical Holdings Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Taisho Pharmaceutical Holdings Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed report …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆